Premium
Fine needle aspiration biopsy of the spleen in pyrexia of unknown origin
Author(s) -
Rajwanshi A.,
Gupta D.,
Kapoor S.,
Kochhar R.,
Gupta† S.,
Varma† S.,
Gupta S.
Publication year - 1999
Publication title -
cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.512
H-Index - 48
eISSN - 1365-2303
pISSN - 0956-5507
DOI - 10.1046/j.1365-2303.1999.00170.x
Subject(s) - medicine , tuberculosis , fine needle aspiration , biopsy , spleen , lymphoma , retrospective cohort study , radiology , sarcoma , autopsy , pathology
Fine needle aspiration biopsy of the spleen in pyrexia of unknown origin To evaluate the diagnostic utility, value and potential risk of fine needle aspiration biopsy of spleen (sFNAB) in patients with splenomegaly in pyrexia of unknown origin (PUO), a retrospective analysis of medical records and cytological material of 31 patients on whom FNAB was performed between April 1994 and October 1997 was done. The patients were HIV − and presented with PUO. All other relevant investigations were negative. The spleen was either palpable or detected to have space‐occupying lesions on ultrasonography (USG). The splenic aspirates showed tuberculosis in 11 patients (35.4%) and inconclusive or reactive changes in nine patients (25.8%). One case out of this group proved to be Kaposi's sarcoma on autopsy. The other diseases encountered were leishmaniasis ( n = 3), non‐Hodgkin's lymphoma ( n = 4), fungal infections ( n = 2), Hodgkin's lymphoma ( n = 1). The patients who were diagnosed as having tuberculosis had epithelioid cells, giant cells, necrosis and inflammatory cells in various combinations. AFB positivity was 63.6%. The other cases which showed granulomas but no AFB were diagnosed on empirical grounds and all responded to the anti‐tuberculosis therapy. No complications were encountered with the procedure. Therefore the authors conclude that sFNAB is rewarding in patients where all other non‐invasive modalities of diagnosis have failed.